Restoration of normal interleukin-2 production by CD4+ T cells of human immunodeficiency virus-infected patients after 9 months of highly active antiretroviral therapy

Journal of Infectious Diseases

Volumn 180, Issue 4, 1999, Pages 1057-1063

  Weiss, Laurence ^a,c   Ancuta, Petronela ^a   Girard, Pierre Marie ^b   Bouhlal, Hicham ^a   Roux, Anne ^a   Cavaillon, Nicole Haeffner ^a   Kazatchkine, Michel D ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL ROTHSCHILD   (France)

^c HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INDINAVIR; INTERLEUKIN 2; LAMIVUDINE; STAVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MIDDLE AGED; MONITORING, IMMUNOLOGIC; T-LYMPHOCYTES; TIME FACTORS;

EID: 0033372246     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315025     Document Type: Article

References (36)

1. Lane HC, Depper, JM, Greene WC, Whalen G, Waldmann TA, Fauci AS. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med 1985;313:79-84.
2. Miedema F, Petit AJ, Terpstra FG, et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin invest 1988; 82:1908-14.
3. Clerici M, Stocks NI, Zajac RA, et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest 1989; 84:1892-9.
4. Krowka JF, Stites DP, Jain S, et al. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. J. Clin Invest 1989; 83:1198-203.
5. Miedema F, Meyaard L, Koot M, et al. Changing virus-host interactions in the course of HIV-1 infection. Immunol Rev 1994; 140:35-72.
6. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997;337:734-9.
7. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997;337:725-33.
8. Piketty C, Castiel P, Belec L, et al. Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease. AIDS 1998; 12:745-50.
9. Pakker NG, Notermans DW, de Boer RJ, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 1998; 4:208-14.
10. Roederer M, Getting to the HAART of T cell dynamics [news; comment]. Nat Med 1998; 4:145-6.
11. Fleury S, de Boer RJ, Rizzardi GP, et al. Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy. Nat Med 1998; 4:794-801.
12. Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis. 1996;173:321-9.
13. Autran B, Garcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997; 277:112-6.
14. Gray CM, Schapiro JM, Winters MA, Merigan TC. Changes in CD4+ and CD8+ T cell subsets in response to highly active. AIDS Rees Hum Retroviruses 1998; 14:561-9.
15. Lederman MM, Connick E, Landay A, et al Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. J Infect Dis 1998; 178:70-9.
16. Hogg RS, O'Shaughnessy MV, Gataric N, et al. Decline in deaths from AIDS due to new antiretrovirals [letter]. Lancet 1997;349:1294.
17. Palella FJ, Jr., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
18. Li TS, Tubiana R, Katlama G Calvez V, Ait Mohand H, Autran B. Longlasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998; 351:1682-86.
19. Testi R, Phillips JH, Lanier LL. Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein Kinase C. J Immunol 1989; 142:1854-60.
20. Bell EB, Sparshott SM, Bunce C. CD4+ T-cell memory, CD45R subsets and the persistence of antigen-a unifying concept. Immunol Today 1998; 19:60-4.
21. Walker RE, Carter CS, Muul L, et al. Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults. Nat Med 1998; 4:852-6.
22. Connors M, Kovacs JA, Krevat S, et al. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 1997; 3:533-40.
23. Withers-Ward ES, Amado RG, Koka PS, et al. Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy. Nat Med 1997; 3:1102-9.
24. McCune JM, Loftus R, Schmidt DK, et al. High prevalence of thymic tissue in adults with human immunodeficiency. J Clin Invest 1998; 101:2301-8.
25. Douek D, Mc Farland R, Keiser P, et al. Thymic contribution to Immune Reconstitution. In: The 6th conference on retroviruses and opportunistic infections. Chicago, 31 January 4 February, 1999.
26. Levy Y, Capitant C, Houhou I, et al. Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection; a randomised controlled trial. ANRS 048 study group. Lancet 1999; 353(9168):1923-9.
27. Natarajan V, Bosche M, Metcalf JA, Ward DJ, Lane HC, Kovacs JA, HIV-1 replication in patients with undetectable plasma virus receiving Highly active antiretroviral therapy [letter]. Lancet 1999; 353:119-20.
28. Fiorentiono S, Dalod M, Olive D, Guillet JG, Gomard E Predominant involvement of CD8+CD28- lymphocytes in human immunodeficiency virus-specific cytotoxic activity. J Virol 1996; 70:2022-6.
29. Borthwick NJ, Bofill M, Gombert WM, et al. Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cell. AIDS 1994; 8:431-41.
30. Roos MT, Miedema F, Meinesz AP, et al. Low T cell reactivity to combined CD3 plus CD28 stimulation is predictive for progression to AIDS: correlation with decreased CD28 expression. Clin Exp Immunol 1996; 105:409-15.
31. Westby M, Marriott JB, Guçkian M, Cookson S, Hay P, Dalgleish AG. Abnormal intracellular IL-2 and interferon-gamma (IFN-gamma) production as HIV-1-associated markers of immune dysfunction. Clin Exp Immunol 1998; 111:257-63.
32. Meyaard L, Hovenkamp E, Keet IP, et al. Single cell analysis of IL-4 and IFN-gamma production by T cells from HIV-infected individuals; de-creased IFN-gamma in the presence of preserved IL-4 production. J Immunol 1996; 157:2712-8.
33. Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, Meroni PL. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994;8:757-62.
34. Fan J. Buss HZ Fahey JL. Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection J Immunol 1993; 151:5031-40.
35. Angel JB, Kumar A, Parato K, et al. Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir. J Infect Dis 1998; 177:898-904.
36. Gorochov G, Neumann AU, Kereveur A et al. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nut Med 1998; 4:215-21.